Literature DB >> 18250468

A CD8+/CD103high T cell subset regulates TNF-mediated chronic murine ileitis.

Johnson Ho1, Courtney C Kurtz, Makoto Naganuma, Peter B Ernst, Fabio Cominelli, Jesús Rivera-Nieves.   

Abstract

Recruitment of lymphocytes to sites of inflammation requires the sequential engagement of adhesion molecules and chemokine receptors. Of these, the lectin-like molecule CD44 has been particularly implicated in inflammatory trafficking. Using a TNF-driven model of chronic ileitis (i.e., B6.129P-Tnf(Delta)(ARE) mice) that recapitulates many features of Crohn's disease, we demonstrate dynamic changes in the expression and functional state of CD44 on CD8+ T cells. These cells coexpress CD44 and L-selectin, giving them a surface phenotype similar to that of central memory T cells. Yet functionally they exhibit the phenotype of effector T cells, because they produce IFN-gamma. Unexpectedly, depletion of the CD8+ population had no effect on the severity of ileitis. Further analyses showed a second CD8+ population that lacked CD44, but expressed CD103, produced TGF-beta, inhibited the proliferation of CD4+ in vitro, and attenuated adoptively transferred ileitis in vivo, most likely counteracting the proinflammatory role of the CD44(high) subset. Collectively, these data suggest that the presence or absence of CD44 and CD103 on the CD8+ lymphocyte surface defines functionally distinct subsets of CD8+ T cells in vivo. These inflammation-driven populations exert distinct roles during the development of chronic ileitis, and influence the balance of effector and regulatory functions in the chronically inflamed small intestine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18250468      PMCID: PMC3036968          DOI: 10.4049/jimmunol.180.4.2573

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

1.  IL-4-producing CD8+ T cells with a CD62L++(bright) phenotype accumulate in a subgroup of older adults and are associated with the maintenance of intact humoral immunity in old age.

Authors:  Susanne Schwaiger; Anna Maria Wolf; Peter Robatscher; Brigitte Jenewein; Beatrix Grubeck-Loebenstein
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

2.  Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells.

Authors:  Joachim Lehmann; Jochen Huehn; Maurus de la Rosa; Frank Maszyna; Ute Kretschmer; Veit Krenn; Monika Brunner; Alexander Scheffold; Alf Hamann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-19       Impact factor: 11.205

3.  Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells.

Authors:  Christian Mottet; Holm H Uhlig; Fiona Powrie
Journal:  J Immunol       Date:  2003-04-15       Impact factor: 5.422

Review 4.  The role of CD94/NKG2 in innate and adaptive immunity.

Authors:  Anasuya Gunturi; Rance E Berg; James Forman
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

5.  Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease.

Authors:  Timothy S Olson; Giorgos Bamias; Makoto Naganuma; Jesús Rivera-Nieves; Tracy L Burcin; William Ross; Margaret A Morris; Theresa T Pizarro; Peter B Ernst; Fabio Cominelli; Klaus Ley
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

Review 6.  Control of immune pathology by regulatory T cells.

Authors:  Fiona Powrie; Simon Read; Christian Mottet; Holm Uhlig; Kevin Maloy
Journal:  Novartis Found Symp       Date:  2003

7.  CCL25 mediates the localization of recently activated CD8alphabeta(+) lymphocytes to the small-intestinal mucosa.

Authors:  Marcus Svensson; Jan Marsal; Anna Ericsson; Laura Carramolino; Therese Brodén; Gabriel Márquez; William W Agace
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

8.  The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7.

Authors:  Veronika Szanya; Joerg Ermann; Cariel Taylor; Claire Holness; C Garrison Fathman
Journal:  J Immunol       Date:  2002-09-01       Impact factor: 5.422

9.  Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn's-like inflammatory bowel disease.

Authors:  Dimitris Kontoyiannis; George Boulougouris; Menelaos Manoloukos; Maria Armaka; Maria Apostolaki; Theresa Pizarro; Alexey Kotlyarov; Irmgard Forster; Richard Flavell; Matthias Gaestel; Philip Tsichlis; Fabio Cominelli; George Kollias
Journal:  J Exp Med       Date:  2002-12-16       Impact factor: 14.307

10.  Ectopic LT alpha beta directs lymphoid organ neogenesis with concomitant expression of peripheral node addressin and a HEV-restricted sulfotransferase.

Authors:  Danielle L Drayton; Xiaoyan Ying; Jason Lee; Werner Lesslauer; Nancy H Ruddle
Journal:  J Exp Med       Date:  2003-05-05       Impact factor: 14.307

View more
  35 in total

1.  Flt3 ligand expands CD103⁺ dendritic cells and FoxP3⁺ T regulatory cells, and attenuates Crohn's-like murine ileitis.

Authors:  Colm B Collins; Carol M Aherne; Eóin N McNamee; Matthew D P Lebsack; Holger Eltzschig; Paul Jedlicka; Jesús Rivera-Nieves
Journal:  Gut       Date:  2011-11-07       Impact factor: 23.059

Review 2.  CD8(+) Tregs in autoimmunity: learning "self"-control from experience.

Authors:  Sue Tsai; Xavier Clemente-Casares; Pere Santamaria
Journal:  Cell Mol Life Sci       Date:  2011-06-14       Impact factor: 9.261

3.  Regulatory T Cells: Concept, Classification, Phenotype, and Biological Characteristics.

Authors:  Yang Du; Qiannan Fang; Song-Guo Zheng
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Ultrasound-based molecular imaging and specific gene delivery to mesenteric vasculature by endothelial adhesion molecule targeted microbubbles in a mouse model of Crohn's disease.

Authors:  José L Tlaxca; Joshua J Rychak; Peter B Ernst; Prasad R Konkalmatt; Talent I Shevchenko; Theresa T Pizarro; Theresa T Pizzaro; Jesús Rivera-Nieves; Alexander L Klibanov; Michael B Lawrence
Journal:  J Control Release       Date:  2012-11-08       Impact factor: 9.776

5.  Transforming growth factor β signaling controls activities of human intestinal CD8(+)T suppressor cells.

Authors:  Keren M Rabinowitz; Yuanyuan Wang; Edward Y Chen; Zara Hovhannisyan; David Chiang; M Cecilia Berin; Stephanie Dahan; Damien Chaussabel; Avi Ma'ayan; Lloyd Mayer
Journal:  Gastroenterology       Date:  2012-12-08       Impact factor: 22.682

6.  CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo.

Authors:  Mehdi Rashighi; Priti Agarwal; Jillian M Richmond; Tajie H Harris; Karen Dresser; Ming-Wan Su; Youwen Zhou; April Deng; Christopher A Hunter; Andrew D Luster; John E Harris
Journal:  Sci Transl Med       Date:  2014-02-12       Impact factor: 17.956

7.  Hematopoietic mobilization: Potential biomarker of response to natalizumab in multiple sclerosis.

Authors:  Miriam Mattoscio; Richard Nicholas; Maria P Sormani; Omar Malik; Jean S Lee; Adam D Waldman; Francesco Dazzi; Paolo A Muraro
Journal:  Neurology       Date:  2015-03-11       Impact factor: 9.910

Review 8.  Inhibitory CD8+ T cells in autoimmune disease.

Authors:  Masakatsu Suzuki; Christine Konya; Jörg J Goronzy; Cornelia M Weyand
Journal:  Hum Immunol       Date:  2008-09-21       Impact factor: 2.850

9.  CD44 deficiency attenuates chronic murine ileitis.

Authors:  Colm B Collins; Johnson Ho; Theodore E Wilson; Joshua D Wermers; José L Tlaxca; Michael B Lawrence; Michael Solga; Joanne Lannigan; Jesús Rivera-Nieves
Journal:  Gastroenterology       Date:  2008-09-06       Impact factor: 22.682

10.  Antibody-suppressor CD8+ T Cells Require CXCR5.

Authors:  Jason M Zimmerer; Bryce A Ringwald; Steven M Elzein; Christina L Avila; Robert T Warren; Mahmoud Abdel-Rasoul; Ginny L Bumgardner
Journal:  Transplantation       Date:  2019-09       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.